Positron emission tomography of high-grade gliomas.

作者: Guido Frosina

DOI: 10.1007/S11060-016-2077-1

关键词:

摘要: High-grade gliomas [HGG (WHO grades III-IV)] are almost invariably fatal. Imaging of HGG is important for orientating diagnosis, prognosis and treatment planning crucial development novel, more effective therapies. Given the potentially unlimited number usable tracing molecules elevated available radionuclides, PET allows gathering multiple informations on including data tissue metabolism drug pharmacokinetics. studies carried out by most frequently used tracers radionuclides ((11)C (18)F) published in 2014 have been reviewed. These demonstrate that a thorough choice may confer diagnostic prognostic power to imaging HGG. They also suggest combination MRI give complete reliable information research hybrid PET/MRI be paying back terms improved these deadly tumours.

参考文章(60)
Huan He, Carol L. Nilsson, Mark R. Emmett, Alan G. Marshall, Roger A. Kroes, Joseph R. Moskal, Yongjie Ji, Howard Colman, Waldemar Priebe, Frederick F. Lang, Charles A. Conrad, Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation Journal of Proteome Research. ,vol. 9, pp. 2098- 2108 ,(2010) , 10.1021/PR900793A
M. Hutterer, E. Hattingen, C. Palm, M. A. Proescholdt, P. Hau, Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Neuro-oncology. ,vol. 17, pp. 784- 800 ,(2015) , 10.1093/NEUONC/NOU322
Marc HA Jansen, Reina W Kloet, Dannis G van Vuurden, Sophie EM Veldhuijzen van Zanten, Birgit I Witte, Serge Goldman, W Peter Vandertop, Emile FI Comans, Otto S Hoekstra, Ronald Boellaard, Gert-Jan JL Kaspers, 18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma. EJNMMI research. ,vol. 4, pp. 8- 8 ,(2014) , 10.1186/2191-219X-4-8
Kohei Hanaoka, Tadashi Watabe, Sadahiro Naka, Yasukazu Kanai, Hayato Ikeda, Genki Horitsugi, Hiroki Kato, Kayako Isohashi, Eku Shimosegawa, Jun Hatazawa, FBPA PET in boron neutron capture therapy for cancer : prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model EJNMMI research. ,vol. 4, pp. 70- 70 ,(2014) , 10.1186/S13550-014-0070-2
Fen Zhao, Yunfeng Cui, Minghuan Li, Zheng Fu, Zhaoqiu Chen, Li Kong, Guoren Yang, Jinming Yu, Prognostic value of 3′-Deoxy-3′-18F-Fluorothymidine ([18F] FLT PET) in patients with recurrent malignant gliomas ☆ Nuclear Medicine and Biology. ,vol. 41, pp. 710- 715 ,(2014) , 10.1016/J.NUCMEDBIO.2014.04.134
Maximilian Niyazi, Nathalie Lisa Jansen, Maya Rottler, Ute Ganswindt, Claus Belka, None, Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients. Radiation Oncology. ,vol. 9, pp. 299- 299 ,(2014) , 10.1186/S13014-014-0299-Y
Nathalie L Jansen, Bogdana Suchorska, Vera Wenter, Sabina Eigenbrod, Christine Schmid-Tannwald, Andreas Zwergal, Maximilian Niyazi, Mark Drexler, Peter Bartenstein, Oliver Schnell, Jörg-Christian Tonn, Niklas Thon, Friedrich-Wilhelm Kreth, Christian la Fougère, None, Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients The Journal of Nuclear Medicine. ,vol. 55, pp. 198- 203 ,(2014) , 10.2967/JNUMED.113.122333
D. O. Kamson, S. Mittal, N. L. Robinette, O. Muzik, W. J. Kupsky, G. R. Barger, C. Juhasz, Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma Neuro-oncology. ,vol. 16, pp. 1373- 1383 ,(2014) , 10.1093/NEUONC/NOU042
G. Morana, A. Piccardo, C. Milanaccio, M. Puntoni, P. Nozza, A. Cama, D. Zefiro, M. Cabria, A. Rossi, M. L. Garre, Value of 18F-3,4-Dihydroxyphenylalanine PET/MR Image Fusion in Pediatric Supratentorial Infiltrative Astrocytomas: A Prospective Pilot Study The Journal of Nuclear Medicine. ,vol. 55, pp. 718- 723 ,(2014) , 10.2967/JNUMED.113.125500